144 related articles for article (PubMed ID: 33018178)
1. Early Detection of Amyloid β Pathology in Alzheimer's Disease by Molecular MRI
Dong CM; Guo AS; To A; Chan KWY; Chow ASF; Bian L; Leong ATL; Wu EX
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1100-1103. PubMed ID: 33018178
[TBL] [Abstract][Full Text] [Related]
2. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.
Maiti P; Hall TC; Paladugu L; Kolli N; Learman C; Rossignol J; Dunbar GL
Histochem Cell Biol; 2016 Nov; 146(5):609-625. PubMed ID: 27406082
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional Superparamagnetic Iron Oxide Nanoparticles Conjugated with Aβ Oligomer-Specific scFv Antibody and Class A Scavenger Receptor Activator Show Early Diagnostic Potentials for Alzheimer's Disease.
Liu XG; Zhang L; Lu S; Liu DQ; Zhang LX; Yu XL; Liu RT
Int J Nanomedicine; 2020; 15():4919-4932. PubMed ID: 32764925
[TBL] [Abstract][Full Text] [Related]
5. Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin.
Maiti P; Plemmons A; Bowers Z; Weaver C; Dunbar G
J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736502
[TBL] [Abstract][Full Text] [Related]
6. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
8. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
[TBL] [Abstract][Full Text] [Related]
9. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
[TBL] [Abstract][Full Text] [Related]
10. Highly sensitive Curcumin-conjugated nanotheranostic platform for detecting amyloid-beta plaques by magnetic resonance imaging and reversing cognitive deficits of Alzheimer's disease via NLRP3-inhibition.
Ruan Y; Xiong Y; Fang W; Yu Q; Mai Y; Cao Z; Wang K; Lei M; Xu J; Liu Y; Zhang X; Liao W; Liu J
J Nanobiotechnology; 2022 Jul; 20(1):322. PubMed ID: 35836190
[TBL] [Abstract][Full Text] [Related]
11. A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid β aggregation in Alzheimer's disease.
Huo X; Zhang Y; Jin X; Li Y; Zhang L
J Photochem Photobiol B; 2019 Jan; 190():98-102. PubMed ID: 30504054
[TBL] [Abstract][Full Text] [Related]
12. RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.
Hadar A; Milanesi E; Squassina A; Niola P; Chillotti C; Pasmanik-Chor M; Yaron O; Martásek P; Rehavi M; Weissglas-Volkov D; Shomron N; Gozes I; Gurwitz D
Transl Psychiatry; 2016 Oct; 6(10):e909. PubMed ID: 27701409
[TBL] [Abstract][Full Text] [Related]
13. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
[TBL] [Abstract][Full Text] [Related]
14. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
15. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model.
He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM
Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120
[TBL] [Abstract][Full Text] [Related]
16. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
Kaya I; Zetterberg H; Blennow K; Hanrieder J
ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
[TBL] [Abstract][Full Text] [Related]
17. Contrast Enhanced Magnetic Resonance Imaging of Amyloid-β Plaques in a Murine Alzheimer's Disease Model.
Sulheim E; WiderØe M; Bäck M; Nilsson KPR; Hammarström P; Nilsson LNG; Davies CL; Åslund AKO
J Alzheimers Dis; 2023; 93(2):411-419. PubMed ID: 37038807
[TBL] [Abstract][Full Text] [Related]
18. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
19. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
[TBL] [Abstract][Full Text] [Related]
20.
Lerouge F; Ong E; Rositi H; Mpambani F; Berner LP; Bolbos R; Olivier C; Peyrin F; Apputukan VK; Monnereau C; Andraud C; Chaput F; Berthezène Y; Braun B; Jucker M; Åslund AK; Nyström S; Hammarström P; R Nilsson KP; Lindgren M; Wiart M; Chauveau F; Parola S
Nanomedicine (Lond); 2022 Dec; 17(29):2173-2187. PubMed ID: 36927004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
